Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement

Completed · Not applicable

Conditions studied: Liver Diseases

In brief

The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.

Key facts

Study ID

NCT06336850

Run by

Methodist Health System

People needed

100

Starts

2020-12-23

Expected to finish

2023-10-17

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Patient who has been referred for EUS procedure and direct PPG measurement and -undergoing EUS-guided liver biopsy
• History of liver disease or suspected cirrhosis and considered for PPGM

You may not qualify if…

• Patient is less than 18 or greater than 85 years of age
• Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study
• Patient is unwilling or unable to sign and date the informed consent
• Patient for whom endoscopic procedures are contraindicated.

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.